These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery. Ahmad G; Amiji M Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075 [TBL] [Abstract][Full Text] [Related]
8. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research]. Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746 [TBL] [Abstract][Full Text] [Related]
9. Strategies for nonviral nanoparticle-based delivery of CRISPR/Cas9 therapeutics. Chen F; Alphonse M; Liu Q Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 May; 12(3):e1609. PubMed ID: 31797562 [TBL] [Abstract][Full Text] [Related]
10. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges. Mout R; Ray M; Lee YW; Scaletti F; Rotello VM Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568 [TBL] [Abstract][Full Text] [Related]
11. Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy. Wang L; Zheng W; Liu S; Li B; Jiang X Chembiochem; 2019 Mar; 20(5):634-643. PubMed ID: 30393919 [TBL] [Abstract][Full Text] [Related]
12. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum. Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843 [TBL] [Abstract][Full Text] [Related]
13. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis. Hong KQ; Liu DY; Chen T; Wang ZW World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229 [TBL] [Abstract][Full Text] [Related]
14. Novel Strategy to Combat Antibiotic Resistance: A Sight into the Combination of CRISPR/Cas9 and Nanoparticles. Wan F; Draz MS; Gu M; Yu W; Ruan Z; Luo Q Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33800235 [TBL] [Abstract][Full Text] [Related]
15. Lipid and polymer mediated CRISPR/Cas9 gene editing. Gong Y; Tian S; Xuan Y; Zhang S J Mater Chem B; 2020 May; 8(20):4369-4386. PubMed ID: 32364557 [TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery. Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612 [TBL] [Abstract][Full Text] [Related]
17. Development and application of CRISPR/Cas9 technologies in genomic editing. Zhang C; Quan R; Wang J Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822 [TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas9 for cancer therapy: Opportunities and challenges. Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591 [TBL] [Abstract][Full Text] [Related]
19. Nanotechnology and CRISPR/Cas9 system for sustainable agriculture. Khanna K; Ohri P; Bhardwaj R Environ Sci Pollut Res Int; 2023 Dec; 30(56):118049-118064. PubMed ID: 36973619 [TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics. Givens BE; Naguib YW; Geary SM; Devor EJ; Salem AK AAPS J; 2018 Oct; 20(6):108. PubMed ID: 30306365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]